Prospective validation of dermoscopy-based open-source artificial intelligence for melanoma diagnosis (PROVE-AI study)
Michael A. Marchetti, Veronica Rotemberg(Memorial Sloan Kettering Cancer Center), Nicholas R. Kurtansky(Memorial Sloan Kettering Cancer Center), Megan Dauscher(Memorial Sloan Kettering Cancer Center), Jennifer DeFazio(Memorial Sloan Kettering Cancer Center), Trina Salvador(Memorial Sloan Kettering Cancer Center), Elizabeth Quigley(Memorial Sloan Kettering Cancer Center), Liang Deng(Memorial Sloan Kettering Cancer Center), Sharif Hosein(Memorial Sloan Kettering Cancer Center), Emily A. Cowen(Memorial Sloan Kettering Cancer Center), Zaeem H. Nazir(Memorial Sloan Kettering Cancer Center), Stephen W. Dusza(Memorial Sloan Kettering Cancer Center), Jochen Weber(Microsoft (United States)), Allan C. Halpern(Memorial Sloan Kettering Cancer Center), Ashfaq A. Marghoob, Helen Haliasos(Memorial Sloan Kettering Cancer Center)
Cited by 72
Related Papers
Skin Lesion Analysis Toward Melanoma Detection 2018: A Challenge Hosted by the International Skin Imaging Collaboration (ISIC)
|arXiv (Cornell University)|2019|990
Guidelines of care for the management of primary cutaneous melanoma
|Journal of the American Academy of Dermatology|2018|707
Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms
|JAMA Dermatology|2021|362
Large language models propagate race-based medicine
|npj Digital Medicine|2023|340
Dermoscopic Evaluation of Amelanotic and Hypomelanotic Melanoma
|Archives of Dermatology|2008|304